Researcher profile
Philip McGuire
Affiliations
Organizations
Clinics Hospital of Ribeirão Pretoauthorship · BRCognitive Neuroimaging Labauthorship · FRInstitute of Psychiatry and Neurologyauthorship · PLKing's College Hospitalauthorship · GBKing's College Londonauthorship · GBKings Health Partnersauthorship · GBNational Institute for Health and Care Researchauthorship · GBNIHR Maudsley Biomedical Research Centreauthorship · GBOxford BioMedica (United Kingdom)authorship · GBSouth London and Maudsley NHS Foundation Trustauthorship · GBThe King's Collegeauthorship · USUniversity of Londonauthorship · GBUniversity of Oxfordauthorship · GBWarneford Hospitalauthorship · GB
Public evidence
17 connected articles
Acceptability of cannabidiol as a treatment for people at clinical high risk for psychosis2026 · medRxivDoes cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial.2025 · Europe PMCPSYSCAN multi-centre study: baseline characteristics and clinical outcomes of the clinical high risk for psychosis sample.2025 · Europe PMCLongitudinal evolution of the transdiagnostic prodrome to severe mental disorders: a dynamic temporal network analysis informed by natural language processing and electronic health records.2025 · Europe PMCAssessing Cannabis Use in People with Psychosis.2024 · Europe PMCCannabidiol does not attenuate acute delta-9-tetrahydrocannabinol-induced attentional bias in healthy volunteers: A randomised, double-blind, cross-over study.2024 · Europe PMCInfluence of cannabis use on incidence of psychosis in people at clinical high risk.2023 · Europe PMCDoes cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios.2023 · Europe PMCCannabidiol (CBD) as a novel treatment in the early phases of psychosis.2022 · Europe PMCEye movements in patients in early psychosis with and without a history of cannabis use.2021 · PubMed Central Open AccessCannabis use in patients with early psychosis is associated with alterations in putamen and thalamic shape.
Registered research
Connected studies
Does Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Studynct04605393Reducing the Harmful Effects of Cannabis Use: Finding the Optimal CBD:THC Rationct05170217Testing the Efficacy of the Cannabis Clinic for Patients With Psychosis (CCP) Intervention for Cannabis Use Reduction/Cessation in Patients With First Episode Psychosisnct07245212
Matched by exact identifiers only. Profile data: Corpus/OpenAlex.